Przeciwciała Anti-Virus


Absolute antibody

Absolute Antibody oferuje szereg rekombinowanych przeciwciał przeciwko antygenom wirusowym. Przeciwciała początkowo wytworzono za pomocą klasycznej technologii hybrydomy, technologii prezentacji fagowej lub sekwencjonowania (unieśmiertelnionych) komórek B od zakażonych pacjentów.

 

 

 

 

 

 

Nazwa przeciwciała [klon] Reaktywność Zastosowanie
Anti-3pk [3p-8-1] Human WB
Anti-4-1BB [BBK2 ] Human antagonist, Blocking, IP, FC, IF, IHC
Anti-A14 [BB5.2] Vaccinia virus IP, WB, IF
Anti-AMIGO-1 [AC27] Mouse ELISA, IF, IHC
Anti-AMIGO-1 [AC50] Mouse ELISA, IF, IHC
Anti-ASCL1 [SC72.2] Human ELISA, IHC
Anti-avian infectious bronchitis virus Nucleoprotein [C5P1] avian infectious bronchitis virus WB, ELISA
Anti-Bovine Coronavirus [BCoV1/1] Bovine coronavirus EIA, neutralizing, ELISA, IF
Anti-Bovine coronavirus [SF-3E4] Bovine coronavirus neutralising, WB, ELISA
Anti-Bovine Herpesvirus gD [BoScFv] Bovine Herpesvirus-1 WB, Block, ELISA, IF
Anti-Canarypox Virus [CNPV-5A11] Canarypox virus WB, ELISA, IF
Anti-Canine Parvovirus [scFv] canine parvovirus NTRL, ELISA
Anti-Capsid protein VP3 [VHH-12B] Poliovirus cryo EM, ELISA
Anti-Capsid protein VP3 [VHH-7A] Poliovirus cryo EM, ELISA
Anti-Capsid protein VP3 [VHH-7B] Poliovirus cryo EM, ELISA
Anti-CCR5 [ST6] rhesus macaque, Human depleting, SPR, ELISA, FC
Anti-CD205 [DEC-205] Mouse vaccination
Anti-CD25 [7D4] Mouse depleting, FC
Anti-CD4 [5A8] Human RIA, WB, ELISA, IHC
Anti-CD4 [EDU-2 (B486)] Human FC, IF, IHC
Anti-CD5 [OX-19] Rat inhibit, WB, FC, IHC
Anti-CD81 [CD81K04] Human crystallisation, Neutralisation, FC
Anti-Cedar virus F [19E 7] Cedar henipavirus (Cedar virus) IP, WB
Anti-Cedar virus G [11D5] Cedar henipavirus (Cedar virus) IP
Anti-Cedar virus G [14F3] Cedar henipavirus (Cedar virus) IP, WB
Anti-cFos [C1-82] Human WB, ELISA, IF, IHC
Anti-cFos [C1-84] Human WB, ELISA, IF, IHC
Anti-cFos [C2-58] Human WB, ELISA, IF, IHC
Anti-cFos [C2-66] Human WB, ELISA, IF, IHC
Anti-cFos [S1-54] Human WB, ELISA, IF, IHC
Anti-cFos [S1-71] Human WB, ELISA, IF, IHC
Anti-CMV [EIV-15] Cytomegalovirus NTRL, ELISA
Anti-CMV coat protein [6A1] Cucumber mosaic virus WB, ELISA
Anti-CMV glycoprotein gB [HCMV37] CMV ICC, NTRL, ELISA, IF, IHC-Fr
Anti-Coat protein [DDF-RuV1] Rubella Virus neutralize, ELISA
Anti-Coat protein [DDF-RuV2] Rubella Virus neutralize, ELISA
Anti-Covid-19 & SARS-CoV Nucleocapsid [1C7C7] SARS-CoV, SARS-CoV-2 WB, ELISA, FC, IHC
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)] SARS-CoV, SARS-CoV2 ELISA, IF
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)] SARS-CoV, SARS-CoV2 ELISA, IF
Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022] SARS-CoV-2 (COVID-19) & SARS Coronavirus crystallography, NTRL, SPR, ELISA, IF
Anti-CPV capsid [A3B10 (MAb 8)] canine parvovirus, feline panleukopenia virus IP, NTRL, ELISA
Anti-CPV capsid [Clone 2] canine parvovirus ELISA
Anti-CymMV Coat protein [11A12F5] Cymbidium mosaic virus ELISA
Anti-Cytomegalovirus (CMV) gH glycoprotein [MSL-109] CMV NTRL
Anti-DENV-2 E protein [4G2] Dengue Virus, Flavivirus group, Zika Virus functional assay, ELISA, IF, IHC
Anti-DI/DII domain of Dengue E protein [DV18] Dengue Virus NTRL, ELISA
Anti-DI/DII domain of Dengue E protein [DV78] Dengue Virus NTRL, ELISA
Anti-DIII domain of Dengue E protein (DENV-1 and DENV-3) [DV63] Dengue Virus NTRL, ELISA
Anti-DIII domain of Dengue E protein [DV10] Dengue Virus NTRL, ELISA
Anti-dsRNA [1D3] Virus WB, ELISA, IHC
Anti-dsRNA [9D5 ] Virus WB, ELISA, IHC
Anti-dsRNA [J2] Species independent IP, ELISA, EM, IF, IHC
Anti-dsRNA/ssRNA [P6] Species independent fucntional assay, ELISA
Anti-E protein [13D6] Tick-borne encephalitis virus neutralization, ELISA, IHC
Anti-E protein [14D5] Tick-borne encephalitis virus crystallization, in vitro, in vivo, neutralization, SPR, ELISA
Anti-E protein [Mab 4.2] Louping ill virus, Tick-borne encephalitis virus Cristallization, in vivo, neutralizing, SPR, ELISA, IF
Anti-E protein [T025] Tick-borne encephalitis virus crystallization, in vivo, neutralizing, ELISA, IF
Anti-E-protein DIII (ABDE) [ZV-2] Zika Virus crystallization, SPR, FC
Anti-E-protein DIII (C-C’) [ZV-48] Zika Virus crystallization, NTRL, SPR, FC
Anti-E-protein DIII (C-C’) [ZV-64] Zika Virus crystallization, NTRL, SPR, FC
Anti-E-protein DIII (LR) [ZV-67] Zika Virus crystallization, NTRL, SPR, WB, FC
Anti-E2 A domain [F5] Human Venezuelan Equine Encephalitis Virus crystallization, NTRL
Anti-E2 B domain [3b4c-4] Human Venezuelan Equine Encephalitis Virus crystallization, NTRL, ELISA
Anti-E2 protein [Chk265] Alphaviruses, Chikungunya crystallization, NTRL, ELISA, FC, IF
Anti-Ebola GP [13F6-1-2] Ebola Virus functional assay, neutralizing, SPR, WB, ELISA
Anti-Ebola GP [h-13F6] EBOV (Zaire) IP, SPR, ELISA
Anti-Ebola Nucleoprotein [KZ51] Ebola Virus (Zaire, Ivory Coast, Reston, Sudan) IP, WB, ELISA, IF
Anti-Ebola surface glycoprotein [KZ52] Ebola (Zaire) crystallization, IP, NTRL, IF
Anti-Ebola virus VP35 protein; [6c5] Zaire ebolavirus IP, Western blot, IF
Anti-Envelope glycoprotein Gc [A5] Hantavirus crystallization, SPR
Anti-Envelope protein [ZKA64] Zika Virus enhance, NTRL, ELISA, FC
Anti-Envelope protein [ZKA78] Dengue Virus, Zika Virus enhance, NTRL, ELISA, FC
Anti-Envelope protein domain III [POWV-80] Powassan virus crystallography, neutralizing, ELISA, FC
Anti-F glycoprotein [12B2] Nipah virus functional assay, neutralize
Anti-Feline Calicivirus; [1D7] Feline calicivirus NTRL, ELISA
Anti-FGF12/FHF1 [N94/17] Rat, Human, Mouse IP, IHC
Anti-FGF13/FHF2 [N91/27.1] mouse, rat, Human WB
Anti-FHV-1 [JH2] Feline Herpes Virus cat diagnostics, cat therapeutics, neutralising
Anti-Flavivirus group antigen [D1-4G2-4-15 (4G2)] Dengue Virus, Flaviviridae, West Nile Virus, Yellow Fever Virus, Zika Virus IHC-P, NTRL, WB, ELISA, FC, IF
Anti-GABA(B)R [N93A/49.2] Rat, Human, Mouse IP, PLA, IF
Anti-Gephyrin [GC1] Human WB, ELISA, IF, IHC
Anti-Gephyrin [GC52] Human WB, ELISA, IF, IHC
Anti-Gephyrin [GC92] Human WB, ELISA, IF, IHC
Anti-Gephyrin [GS41] Human WB, ELISA, IF, IHC
Anti-Gephyrin [GS8] Human WB, ELISA, IF, IHC
Anti-GFP [N86/38.1] Aequorea victoria IP, IF, IHC
Anti-Ghana Virus F [7C11-LY] Ghana virus IP, ELISA
Anti-Ghana Virus G [10C4-LY] Ghana virus IP, WB, ELISA
Anti-Ghana Virus G [10D5-LY] Ghana virus IP, WB, ELISA
Anti-Glycoprotein [MR78] Ebola Virus, Marburg Virus neutralize, ELISA
Anti-Glycoprotein B of HSV [Fd79] Herpes Simplex Virus NTRL, FC, IF
Anti-Glycoprotein Complex [37.7H] Lassa virus crystallography, NTRL, WB, ELISA
Anti-Glycoprotein D of HSV [Fd138-80] Herpes Simplex Virus NTRL, FC, IF
Anti-glycoprotein E [19/1786] Tick-borne encephalitis virus Cryo-EM, IP, Neurtalization, WB, ELISA
Anti-Glycoprotein E1 [IGH526 (4805, 48G5C4)] Hepatitis C virus (HCV) functional assay, neutralize, ELISA, FC, IF
Anti-Glycoprotein E2 [19B3] Hepatitis C virus (HCV) functional assay, neutralizing, ELISA
Anti-Glycoprotein E2 [212.1.1] Hepatitis C virus (HCV) functional assay, neutralization, ELISA, FC
Anti-Glycoprotein E2 [AP33] Hepatitis C virus (HCV) functional assay, IP, neutralize, Block, ELISA
Anti-Glycoprotein E2 [HC-11] Hepatitis C virus (HCV) IP, neutralize, ELISA, FC, IF
Anti-Glycoprotein E2 [HC-1AM] Hepatitis C virus (HCV) neutralize, ELISA, FC
Anti-Glycoprotein E2 [HC33.1] Hepatitis C virus (HCV) neutralize, WB, ELISA
Anti-Glycoprotein E2 [HC84.26.5D (HC26AM)] Hepatitis C virus (HCV) IP, neutralize, ELISA
Anti-Glycoprotein H [A13-d6.3] pseudorabies virus (PrV) crystalize, immunostaining, neutralize
Anti-Glycoprotein H [MAb 5] HCMV ELIS, IP, RIA
Anti-GP1 [GD01] Junin virus (JUNV) crystallize, neutralize, ELISA
Anti-HA [8H5] Influenza A Virus (several subtypes) Hemagglutination inhibition test;, NTRL, ELISA
Anti-HA [AV.C4] H5N1 Influenza A Virus NTRL, WB, ELISA
Anti-HA [AV.D1] H5N1 Influenza A Virus NTRL, ELISA
Anti-HA [AV.G4] H5N1 Influenza A Virus WB, ELISA
Anti-HA [CR6261] Influenza A Virus (several subtypes) NTRL, therapeutic
Anti-HA [CR8020] Influenza A Virus (several subtypes) NTRL, therapeutic, FC
Anti-HA [FB75] Influenza A Virus (several subtypes) NTRL, ELISA
Anti-HA [FC41] Influenza A Virus (several subtypes) ELISA
Anti-HA [FE17] Influenza A Virus (several subtypes) ELISA
Anti-HAV IRES domain V [HAVx] Hepatitis A Virus ELISA
Anti-HBeAg [E6] Hep B cross-competition assay, crystallization, Mab: RIA, serum protein electrophoresis. Fab
Anti-HBsAg [5C3] Hepatitis B Virus RIA
Anti-HBsAg [F124 scFv] Hepatitis B Virus ELISA
Anti-HCMV [8F9] Human Cytomegalovirus IP, neutralize, WB, ELISA, FC
Anti-HCMV gB [5A6] Human cytomegalovirus (HCMV) IP, Neutralisation, FC, IF
Anti-HCMV gB [HCMV37] Human Cytomegalovirus IP, NTRL, ELISA, IF
Anti-HCMV gH [HCMV16] Human Cytomegalovirus IP, NTRL, ELISA, IF
Anti-HCV E1E2 complex [AR4A (N4)] Hepatitis C virus (HCV) IP, neutralize, therapeutic, ELISA, FC
Anti-HCV IRES junction IIIabc [HCV2] Hepatitis C virus therapeutic, ELISA
Anti-HCV NS3 Protein [Hfab-aNS3] Hepatitis C helicase assay, ICC, ELISA
Anti-Hemagglutinin [17/9] Influenza A virus  
Anti-hemagglutinin H1 [3978] Influenza B virus functional assay, ELISA, FC
Anti-hemagglutinin H1 [5589] Influenza A virus functional assay, ELISA, FC
Anti-hemagglutinin H1 [7665] Influenza A virus functional assay, ELISA, FC
Anti-hemagglutinin H3 [1664] Influenza A virus functional assay, ELISA, FC
Anti-Hendra and Nipah virus G [48D3] Hendra henipavirus (Hendra virus, HeV), Nipah henipavirus (Nipah virus, NiV) IP, WB
Anti-Hendra and Nipah virus G [5B1] Hendra henipavirus (Hendra virus, HeV), Nipah henipavirus (Nipah virus, NiV) IP, neutralizing
Anti-Hendra and Nipah virus G [7B7] Hendra henipavirus (Hendra virus, HeV), Nipah henipavirus (Nipah virus, NiV) IP, neutralizing
Anti-Hepatitis A virus capsid [R10] Hepatitis A Virus crystallisation, Neutralisation, ELISA
Anti-His tag [4C9] Species independent epitope tag, WB, ELISA
Anti-His tag [H343] Species independent epitope tag, Purification, ELISA
Anti-His tag [H7219] Species independent epitope tag, Purification, ELISA
Anti-HIV capsid protein p24 [13B5] HIV SPR, ELISA
Anti-HIV capsid protein p24 [CB4-1] HIV ELISA
Anti-HIV GP41 [2E7 (L92E7)] HIV-1 NTRL, ELISA
Anti-HIV-1 GP120 [0.5B] HIV-1 IP, NTRL, FC
Anti-HIV-1 gp120 [447-D] HIV-1 (Human immunodeficiency virus 1) functional assays, neutralizing, WB, ELISA, IF
Anti-HIV-1 gp120 [694-D] HIV-1 (Human immunodeficiency virus 1) functional assays, neutralizing, WB, ELISA, IF
Anti-HIV-1 GP120 [b12 (MT12)] HIV-1 neutralize, therapeutic, ELISA
Anti-HIV-1 GP120 [HGD65] HIV-1 NTRL
Anti-HIV-1 GP120 [HGN194] HIV-1 NTRL
Anti-HIV-1 GP120 [HGZ1] HIV-1 NTRL
Anti-HIV-1 GP120 [HJ16] HIV-1 NTRL
Anti-HIV-1 GP120 [HR10] HIV-1 NTRL
Anti-HIV-1 GP120 [HR12] HIV-1 NTRL
Anti-HIV-1 GP120 [PGT124] HIV-1 functional assay, neutralize, ELISA
Anti-HIV-1 GP120 [VRC03] HIV-1 neutralize, SPR, ELISA
Anti-HIV-1 GP120 [X5] HIV-1 functional assay, neutralization, WB, ELISA, FC
Anti-HIV-1 GP120 [YZ18] HIV-1 ELISA, NTRL
Anti-HIV-1 GP120 [YZ23] HIV-1 ELISA, NTRL
Anti-HIV-1 GP41 [HGF24] HIV-1 NTRL
Anti-HIV-1 GP41 [HK20] HIV-1 NTRL
Anti-HN Protein [1A6] Sendai Virus Hemagglutination inhibition, Neutralisation, IF
Anti-HPV16E6 & HPV18E6 [C1P5] Human papilloma virus IP, WB, IHC
Anti-HSV-1 VP5 [6F10-D2-G2] Herpes simplex functional assays, IP, WB, ELISA, IF
Anti-Human Rhinovirus 14 [Fab17-IA] Human Rhinovirus 14 Neutralize;
Anti-iC3b [5D2] Human, Mouse IP, ELISA, IHC
Anti-IFNa 2b [scFv 17] Human ELISA
Anti-IFNA 8 [α8#139] Human Immunoaffinity chromatography, NTRL, RIA, WB, ELISA
Anti-IFNA 8 [α8Y36-2] Human RIA, WB, ELISA
Anti-IFNAR-1 [64G12] Human confocal microscopy, inhibit, IP, NTRL, WB, ELISA, FC, IF
Anti-infectious bursal disease virus [CRAb154] infectious bursal disease virus IP, ELISA
Anti-infectious bursal disease virus VP2 [CRAb 88] very virulent infectious bursal disease virus (CS89) IP, ELISA
Anti-influenza [2-8C] Influenza A virus nucleoprotein (NP) neutralisation assays, virus titration/quantification, WB, ELISA, IF, IHC
Anti-influenza [2-12C] Influenza A virus hemagglutinin glycoprotein (HA) hemagglutination inhibition test, microneutralization assays, virus titration, ELISA, IF
Anti-influenza [3-10B] Influenza B virus nucleoprotein (NP) neutralisation assays
Anti-influenza [T1-3B] Influenza A virus hemagglutinin glycoprotein (HA) hemagglutination inhibition test, microneutralization assays, virus titration, ELISA, IF
Anti-Influenza A HA [FLD127] H5N1 Influenza A Virus NTRL, RIA, ELISA
Anti-Influenza A HA [FLD20] H5N1 Influenza A Virus NTRL
Anti-Influenza A HA [FLD21] H5N1 Influenza A Virus NTRL
Anti-Influenza A HA [FLD84] H5N1 Influenza A Virus NTRL, RIA, ELISA
Anti-Influenza A HA [FLD93] H5N1 Influenza A Virus NTRL
Anti-Influenza A HA [HA] Influenza A Virus (several subtypes) ELISA
Anti-Influenza A nucleoprotein [aNP-VHH1] Influenza A crystallography, IP, EM, FC
Anti-Influenza A virus NS1 [NS1-23-1] Influenza A virus IP, WB
Anti-JEV virions (E/PrM) [TJE12B02] Japanese Encephalitis Virus IP, NTRL, ELISA
Anti-La Crosse virus, G1 envelope glycoprotein [807.15] La Crosse Bunyavirus IP, neutralising assays, viral serology, WB, ELISA, FC
Anti-La Crosse virus, G1 envelope glycoprotein [807.31] La Crosse Bunyavirus IP, neutralising assays, viral serology, WB, ELISA, FC
Anti-LAM [CS-35] Mycobacterium leprae, Mycobacterium tuberculosis, Mycobacterium bovis ELISA;, WB, FC, IF
Anti-LDL receptor [12G4] Hamster, Rat, Human, Mouse Block, ELISA, FC, IHC
Anti-LMP1 [S12] Epstein-Barr virus IB, IP, WB, ELISA, FC, IHC
Anti-LMP2A [14B7] Epstein-Barr virus IB, IP, WB, ELISA, IF
Anti-M13 bacteriophage [E1] M13 phage WB, ELISA, FC, IHC
Anti-Malin [N85/18.1] Human IP, WB, IHC
Anti-Marburg virus nucleoprotein [sdAb 4] Marburg virus (MARV) cross-linking, crystallography, ELISA
Anti-Matrix Protein [E10] Influenza A virus WB, ELISA, FC, IHC
Anti-MERS-CoV Spike protein [1F8] MERS Coronavirus NTRL
Anti-MERS-CoV Spike protein [3A1] MERS Coronavirus NTRL
Anti-MERS-CoV Spike protein [3B12] MERS Coronavirus NTRL
Anti-MERS-CoV Spike Protein [4c2] MERS-CoV crystallization, NTRL, ELISA
Anti-MERS-CoV Spike protein [M14D3] MERS Coronavirus NTRL
Anti-MESD [N88/12.1] Rat, Human, Mouse IP, WB, IHC
Anti-Mojiang Virus F [3C4-LY] Mojiang henipavirus (Mojiang virus, MojV) IP, ELISA
Anti-Mojiang Virus F [4G5-LY] Mojiang henipavirus (Mojiang virus, MojV) IP, WB, ELISA
Anti-Mojiang Virus G [10G2-LY] Mojiang henipavirus (Mojiang virus, MojV) IP, ELISA
Anti-Mojiang Virus G [6E5-LY] Mojiang henipavirus (Mojiang virus, MojV) IP, ELISA
Anti-Monkeypox Virus [VACV-5C7] Monkeypox virus ELISA, IF
Anti-Murine leukemia virus p30 gag capsid polypeptide [R187] Murine leukemia virus IP, IF
Anti-N9 Neuraminidase [NC41 ] Influenza crystallisation
Anti-Neutralizing Epitope [ZKA185] Zika Virus NTRL
Anti-Nipah and Hendra G [nAH1.3] Hendra virus, Nipah virus neutralizing
Anti-Nipah virus F F1 [5G7] Nipah henipavirus (Nipah virus, NiV) IP, WB
Anti-Nipah virus F F2 [11F10] Nipah henipavirus (Nipah virus, NiV) IP, WB
Anti-Nipah virus F F2 [6D3] Nipah henipavirus (Nipah virus, NiV) IP, WB
Anti-Nipah virus F Site I [16C2] Nipah henipavirus (Nipah virus, NiV) IP
Anti-Nipah virus F Site II [4C9] Nipah henipavirus (Nipah virus, NiV) IP
Anti-Nipah virus F Site IV [1E 11] Nipah henipavirus (Nipah virus, NiV) IP
Anti-Nipah virus F1 [13G5] Nipah henipavirus (Nipah virus, NiV) IP, WB
Anti-Norovirus capsid protein VP1 [A1227] Norovirus ELISA
Anti-Norovirus GII.4 [NVB43.9] Norovirus NTRL, Block
Anti-Norovirus GII.4 P domain [A1431] Norovirus neutralize, Block, ELISA
Anti-Norovirus GII.4 VP1 [8E1] Norovirus neutralize, ELISA
Anti-Norovirus P domain [Nano-27] Norovirus crystallography, ITC, neutralisation assay, ELISA
Anti-Norovirus P domain [Nano-4] Norovirus crystallography, ITC, neutralisation assay, ELISA
Anti-Notch 1 [WC613] Human IP, ELISA, FC
Anti-Notch 1 [WC75] Human IP, ELISA, FC
Anti-NP [JS08] SARS-CoV-2 SPR, WB, ELISA
Anti-NP [JS16] SARS-CoV-2 SPR, WB, ELISA
Anti-NS1 [22NS1 ] West Nile Virus crystallography, NTRL, FC
Anti-NS1 [ZKA35] Zika Virus Blockade-of-Binding ELISA, BOB ELISA, Competition ELISA, ELISA
Anti-Orthopoxviruses [VACV-5B1] Orthopoxviruses Immunogold electron microscopy, IP, WB, ELISA, FC, IF
Anti-p35 protein of Orthopoxvirus [1A] Orthopoxvirus WB, ELISA
Anti-Parvovirus [MAbE] canine parvovirus, feline panleukopenia virus IP, Neutralisation, RIA, ELISA, EM
Anti-peptides (neutralizing epitope) [Clone 36] Influenza A (H3N2) ELISA
Anti-PERV [7C4] Porcine Endogenous Retrovirus neutralize, WB, ELISA
Anti-PERV [A5] Porcine Endogenous Retrovirus WB
Anti-PERV p27 [D2] Porcine Endogenous Retrovirus WB
Anti-Poxvirus L1 Protein [Fab 7d11] Poxviruses crystallization, PRNT, ELISA
Anti-pre- and post-fusion conformation of HRSV F protein [RSB15] Respiratory Syncytial Virus (RSV) NTRL, IF
Anti-pre- and post-fusion conformation of HRSV F protein [RSB16] Respiratory Syncytial Virus (RSV) NTRL, IF
Anti-pre-fusion conformation of HRSV F protein [RSB20] Respiratory Syncytial Virus (RSV) NTRL, IF
Anti-pre-fusion conformation of HRSV F protein [RSB43] Respiratory Syncytial Virus (RSV) NTRL, IF
Anti-PRSV coat protein [9G2D3] Papaya ringspot virus ELISA
Anti-Rabies Virus 67kDa protein [EP5G3] Rabies Virus IP, NTRL, WB, ELISA
Anti-Rabies Virus 67kDa protein [Fab094] Rabies Virus IP, NTRL, WB, ELISA
Anti-Rabies Virus 67kDa protein [GD2D12] Rabies Virus IP, NTRL, WB, ELISA
Anti-Rabies Virus Glycoprotein [A11] Rabies virus (Pasteur strain) WB, ELISA
Anti-Rabies Virus Glycoprotein [C12] Rabies virus (CVS-11) ELISA
Anti-Rabies Virus Glycoprotein [R16E5] Rabies Virus NTRL, WB, ELISA
Anti-RRV E2 [D7] Ross River Virus labelling, FC
Anti-RSV [RSHZ19 (Felvizumab)] RSV functional, ELISA
Anti-RSV G protein [131-2G] Respiratory Syncytial Virus (RSV) therapeutic, ELISA
Anti-RSV G protein [CB002.5] Respiratory Syncytial Virus (RSV) neutralize, ELISA
Anti-S protein (RBD) [STE90-C11] SARS-CoV-2 biolayer interferometry, crystallography, in vitro inhibition, in vitro neutralization, in vivo protection, therapeutic, ELISA
Anti-S2 domain [S2A3] MERS SPR, ELISA, IF
Anti-Saint Louis encephalitis virus envelope glycoprotein [6B6C-1] Saint Louis encephalitis virus immunoblot, IP, ELISA
Anti-SAPAP2 [SS88] Rat WB, ELISA, IF, IHC
Anti-SARS-CoV Nucleoprotein [N18] SARS Coronavirus ELISA
Anti-SARS-CoV S glycoprotein [11A] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [1B5] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [256] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [4D4] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [4G2] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [4S1] SARS Coronavirus ELISA, IF
Anti-SARS-CoV S glycoprotein [5D3] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [5E4] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [6B1] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [A11] SARS Coronavirus WB, ELISA, IF
Anti-SARS-CoV S glycoprotein [F26G10] SARS Coronavirus NTRL, ELISA, IF
Anti-SARS-CoV S glycoprotein [F26G19] SARS Coronavirus NTRL, WB, ELISA, IF
Anti-SARS-CoV S glycoprotein [F26G9] SARS Coronavirus NTRL, ELISA, IF
Anti-SARS-CoV S glycoprotein [Lsc18] SARS Coronavirus WB, ELISA, IF
Anti-SARS-CoV S glycoprotein [S109] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [S110] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [S124] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [S215] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [S217] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [S222] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [S223] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [S225] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [S226] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [S227] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [S228] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [S230] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [S231] SARS Coronavirus NTRL, ELISA
Anti-SARS-CoV S glycoprotein [Ssc35] SARS Coronavirus WB, ELISA, IF
Anti-SARS-CoV-2 and SARS-CoV nucleocapsid [mBG17] SARS Coronavirus WB, ELISA, IF
Anti-SARS-CoV-2 nucleocapsid [mBG86] SARS-CoV-2 WB, ELISA, IF
Anti-SARS-CoV-2 Spike protein (RBD monomer) [2B-E7-C9] SARS Coronavirus 2 (SARS-Cov-2) ELISA
Anti-SARS-CoV-2 Spike protein (RBD monomer) [2B-G10-A1] SARS Coronavirus 2 (SARS-Cov-2) ELISA
Anti-SEB [6D3] Staphylococcus aureus ELISA, WB, Inhibit, Block
Anti-Spike protein [EY6A] SARS Coronavirus 2 (SARS-Cov-2) NTRL, Surface Plasmon Resonance, therapeutic, ELISA, IF
Anti-Spike protein [MR17 ] SARS Coronavirus 2 (SARS-Cov-2) biolayer interferometry, FACS, NTRL, therapeutic, ELISA
Anti-Spike protein [MR3] SARS Coronavirus 2 (SARS-Cov-2) biolayer interferometry, FACS, NTRL, therapeutic, ELISA
Anti-Spike protein [Sb23] SARS Coronavirus 2 (SARS-Cov-2) biolayer interferometry, NTRL, ELISA
Anti-Spike protein [SR4] SARS Coronavirus 2 (SARS-Cov-2) biolayer interferometry, FACS, NTRL, therapeutic, ELISA
Anti-Spike protein [Ty1] SARS Coronavirus 2 (SARS-Cov-2) biolayer interferometry, inhibit, NTRL, ELISA, FC, IF
Anti-Spike Protein (RBD) [CV30] SARS Coronavirus 2 neutralize, therapeutic, ELISA, FC
Anti-Spike protein (RBD) [Sb#14] SARS Coronavirus 2 (SARS-Cov-2) grating-coupled interferometry, inhibition, therapeutics, ELISA
Anti-Spike protein (RBD) [Sb#15] SARS Coronavirus 2 (SARS-Cov-2) grating-coupled interferometry, inhibition, therapeutics, ELISA
Anti-Spike protein (RBD) [Sb#16] SARS Coronavirus 2 (SARS-Cov-2) grating-coupled interferometry, inhibition, therapeutics, ELISA
Anti-Spike protein (RBD) [Sb#42] SARS Coronavirus 2 (SARS-Cov-2) grating-coupled interferometry, inhibition, therapeutics, ELISA
Anti-Spike protein (RBD) [Sb#45] SARS Coronavirus 2 (SARS-Cov-2) grating-coupled interferometry, inhibition, therapeutics, ELISA
Anti-Spike protein (RBD) [Sb#68] SARS Coronavirus 2 (SARS-Cov-2) grating-coupled interferometry, inhibition, therapeutics, ELISA
Anti-Spike protein [18F4] SARS Coronavirus 2 (SARS-Cov-2) functional assay, SPR, Block, ELISA
Anti-Spike protein [4A8] SARS Coronavirus 2 (SARS-Cov-2) functional assay, neutralizing, ELISA, FC
Anti-Spike Protein [CV1] SARS Coronavirus 2 neutralize, therapeutic, ELISA, FC
Anti-Spike protein [D70678-5521-S2] SARS Coronavirus 2 (SARS-Cov-2) functional assay, SPR, ELISA
Anti-Tetanus toxoid [F13] Clostridium tetani NTRL, WB, ELISA
Anti-TGEV Coronavirus Spike glycoprotein [1AF10] TGEV coronavirus NTRL, RIA, WB, ELISA
Anti-V5 epitope tag [SV5-P-K] Paramyxovirus Simian Virus 5 IP, RIA, WB, ELISA, IF, IHC-Fr
Anti-Vaccinia A13 protein [11F7] Monkeypox virus, Orthopoxvirus, Vaccinia virus, variola virus neutralize, SPR, WB, ELISA, IF
Anti-Vaccinia A33 glycoprotein [A2C7] Vaccinia virus neutralization, IF
Anti-Vesicular stomatitis virus nucleoprotein N [VHH-1004] Vesicular stomatitis virus (VSV) LUMIER assays, transcription assays, FC
Anti-VP1 protein [EBB-C1975-B5] BK virus, Human polyomavirus 1 NTRL, ELISA
Anti-VP1 protein [NEG447A] BK virus, Human polyomavirus 1 ELISA
Anti-VP2 [8F5] Human rhinovirus type 2 NTRL, WB, IP, IHC
Anti-VP35 [H3] Marburg Virus crystallography, inhibition, ELISA
Anti-VSV-M [23H12] Vesicular stomatitis Indiana virus WB, IF
Anti-VSV-N [10G4] Vesicular stomatitis Indiana virus WB
Anti-WNV Envelope protein [9E2] West Nile Virus NTRL, WB
Anti-WNV Envelope protein DI-DII [E53] West Nile Virus crystallography, NTRL
Anti-Yellow Fever Virus [2D12] Yellow Fever Virus functional assay, RIA, ELISA, FC, IF
Anti-ZIKV E domain II [SMZAb2] Zika Virus neutralisation assays, therapeutic, ELISA
Anti-ZIKV E domain III [SMZAb1] Zika Virus neutralisation assays, therapeutic, ELISA
Anti-ZIKV E domain III [SMZAb5] Zika Virus neutralisation assays, therapeutic, ELISA
Anti-ZIKV E domain III [Z004] DENV1 virus, Zika Virus crystallography, neutralisation assays, ELISA
Anti-ZIKV soluble envelope protein [z23] Zika Virus Block




Produkt

Aktualne promocje

ZAPRASZAMY DO ZAPOZNANIA SIĘ Z PRZECIWCIAŁAMI CYTOMETRYCZNYMI FIRMY ELABSCIENCE.

SZEROKI WYBÓR FLUOROCHROMÓW POZWALA NA DOKŁADNE DOPASOWANIE PRZECIWCIAŁ DO SPECYFIKI BADAŃ

OBECNIE WSZYSTKIE PRODUKTY TEJ KATEGORII DOSTĘPNE SĄ Z RABATEM 10%

Dowiedz się więcej

Nasi partnerzy